Mirabella Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,703
Closed -$337K 669
2023
Q4
$337K Buy
+11,703
New +$354K 0.04% 263
2023
Q2
Sell
-33,473
Closed -$1.37M 616
2023
Q1
$1.37M Buy
33,473
+25,580
+324% +$1.1M 0.21% 91
2022
Q4
$404K Buy
7,893
+510
+7% +$24.5K 0.04% 219
2022
Q3
$326K Buy
+7,383
New +$359K 0.03% 211
2022
Q2
Sell
-74,776
Closed -$3.87M 656
2022
Q1
$3.87M Buy
+74,776
New +$3.88M 0.43% 35
2021
Q3
Sell
-13,238
Closed -$519K 517
2021
Q2
$519K Sell
13,238
-57,189
-81% -$2.22M 0.09% 161
2021
Q1
$2.55M Buy
+70,427
New +$2.5M 0.79% 37
2020
Q4
Sell
-145,459
Closed -$5.07M 442
2020
Q3
$5.07M Buy
145,459
+135,515
+1,363% +$4.75M 0.69% 13
2020
Q2
$309K Buy
+9,944
New +$338K 0.07% 120

Other funds holding PFE

Mirabella Financial Services's PFE Position: Q1 2024 in Review

Mirabella Financial Services sold out of Pfizer (PFE) in Q1 2024, closing a stake of 11,703 shares — an estimated $337K sold.

Mirabella Financial Services first reported a position in PFE in Q2 2020 and held it in 9 quarters. The position peaked at $5.07M in Q3 2020. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Mirabella Financial Services reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 11,703 Pfizer shares in Q1 2024, an estimated $337K.
  • Mirabella Financial Services first reported a position in Pfizer in Q2 2020 and held it in 9 quarters.
  • Mirabella Financial Services's Pfizer position peaked at $5.07M in Q3 2020.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Mirabella Financial Services's 13F filing for Q1 2024, filed 15 May 2024.